Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hiltonol and Dendritic Cells in Solid Tumors
NCT01734564Phase 2Completed
- Sponsor
- Universidad de Navarra
- Start
- Nov 2012
- Primary completion
- Dec 2016
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
Phase 2, open-label trial of poly iclc in solid tumor (2 arms), sponsored by Universidad de Navarra. Primary endpoint: Response rate. Started Nov 2012; status: completed.
02
Drugs
poly iclc
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01734564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01734564.